Idiopathic Thrombocytopenic Purpura in Patients with Ischaemic Heart Disease - A Therapeutic Challenge

Authors

  • AKM Monwarul Islam Associate Professor, Department of Cardiology, National Institute of Cardiovascular Diseases, Dhaka
  • Tanveer Ahmed Specialist, Department of Cardiology, United Hospital Ltd., Dhaka
  • Ishrat Jahan Shimu Assistant Registrar, Department of Cardiology, National Institute of Cardiovascular Diseases, Dhaka
  • Samsun Nahar Specialist, Department of Cardiology, United Hospital Ltd., Dhaka
  • Mohammad Arifur Rahman Junior Consultant, Department of Cardiology, National Institute of Cardiovascular Diseases, Dhaka
  • Afzalur Rahman Afzalur Rahman, Director and Professor, National Institute of Cardiovascular Diseases, Dhaka

DOI:

https://doi.org/10.3329/bhj.v33i1.37029

Keywords:

Idiopathic Thrombocytopenic Purpura, Coronary Artery Disease, Thrombocytopenia

Abstract

Idiopathic thrombocytopenic purpura (ITP) and myocardial infarction (MI) in an individual patient is a rare combination. MI mandates thrombolytic and antiplatelet therapy which increases the risk of bleeding in ITP. So far, no guideline deals with management protocol for ischaemic heart disease (IHD) in ITP patients. Here, we describe 2 cases of IHD who developed ITP while on antiplatelet therapy.

Bangladesh Heart Journal 2018; 33(1) : 74-77

Downloads

Abstract
54
PDF
63

Author Biography

AKM Monwarul Islam, Associate Professor, Department of Cardiology, National Institute of Cardiovascular Diseases, Dhaka



Downloads

Published

2018-07-03

How to Cite

Islam, A. M., Ahmed, T., Shimu, I. J., Nahar, S., Rahman, M. A., & Rahman, A. (2018). Idiopathic Thrombocytopenic Purpura in Patients with Ischaemic Heart Disease - A Therapeutic Challenge. Bangladesh Heart Journal, 33(1), 74–77. https://doi.org/10.3329/bhj.v33i1.37029

Issue

Vol. 33 No. 1 (2018)

Section

Case Reports

License

© Bangladesh Cardiac Society.  

Creative Commons Licence
Articles in the Bangladesh Heart Journal are Open Access articles published under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC).  This license permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.